EP0430539A2 — Ocular implants
Assigned to Oculex Pharmaceuticals Inc · Expires 1991-06-05 · 35y expired
What this patent protects
Ocular implants are formed so as to be insertable in the suprachoroid of the eye, preferably in the form of plaques 0.5 to 10 mm x 0.5 to 10 mm, and 0.25 to 1.0 mm thick. They are made from a pharmacologically acceptable biodegradable polymer, such as a polyester, incorporating a…
USPTO Abstract
Ocular implants are formed so as to be insertable in the suprachoroid of the eye, preferably in the form of plaques 0.5 to 10 mm x 0.5 to 10 mm, and 0.25 to 1.0 mm thick. They are made from a pharmacologically acceptable biodegradable polymer, such as a polyester, incorporating an active agent for treating an eye condition, for example an anti-tumour agent.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.